Riskpilot← Back to searchSign inGet full accessMAXFAC DENTAL AS
ASActiveOrg 995824906Holmenveien 5G, 0374 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 20103 employeeswww.maxfac.no
Revenue 2025
NOK 2,2M
-18% vs 2024
EBITDA margin
25.6%
+95% vs 2024
Equity ratio
19.9%
Financial strength
Net profit 2025
NOK 416K
+148% vs 2024
| Revenue | NOK 2,2M | -18% |
| EBITDA | NOK 557K | +95% |
| Net profit | NOK 416K | +148% |
| Total assets | NOK 1,2M | -8% |
| Equity | NOK 231K | +0% |
| Employees | 3 | — |
Legal name
MAXFAC DENTAL AS
Org number
995824906
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
17. august 2010
Share capital
NOK 100 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Import og agentur av tannimplantater og andre varer til bruk hos tannleger og helsevirksomheter. Selskapet vil ha videresalg både i norge og gjennom eksport til utlandet. Selskapet vil også ha virksomhet innenfor relatert rådgivning og deltakelse i andre virksomheter.
Address
Holmenveien 5G, 0374 Oslo
Website
www.maxfac.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 223 | 2 806 | 2 034 | 2 663 | 2 172 |
| Staff expenses | −395 | −351 | −304 | −272 | −163 |
| EBITDA | 843 | 736 | 148 | 285 | 557 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 843 | 736 | 148 | 285 | 557 |
| Net financials | −50 | −53 | −46 | −70 | −24 |
| Profit before tax | 793 | 683 | 102 | 215 | 533 |
| Tax | 174 | 150 | 20 | 47 | 117 |
| Net profit | 618 | 533 | 82 | 168 | 416 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 820 | 2 196 | 1 505 | 1 261 | 1 165 |
| Equity | 105 | 154 | 236 | 231 | 231 |
| Long-term debt | 1 215 | 829 | 616 | 433 | 0 |
| Short-term debt | 1 500 | 1 213 | 653 | 598 | 933 |
| Total debt | 2 715 | 2 042 | 1 270 | 1 031 | 933 |
EBITDA margin
25.6%
This company
15.8%
Market median
+62% vs market
20212025
Equity ratio
19.9%
This company
38.2%
Market median
-48% vs market
20212025
Return on equity
179.8%
This company
18.4%
Market median
+877% vs market
20212025
Net profit margin
19.1%
This company
8.1%
Market median
+136% vs market
20212025
Asset turnover
1.87×
This company
1.12×
Market median
+67% vs market
20212025
Debt / equity
4.04×
This company
0.62×
Market median
-552% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
BH Deputy Member | Deputy Member | 2010 |
AC Chief Executive Officer | Chief Executive Officer | 2015 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2010 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Oslo Implantatsenter As
MAXFAC DENTAL AS Board members of MAXFAC DENTAL AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bjørn Hanvold | Deputy Member | 0 companies |
| Ann Christin Næss | Chief Executive Officer | 0 companies |
| Karl Iver Hanvold | Chairman | 0 companies |